Citations

Mayo Clinic

Showing 10 of 108585 citations.

Breast-Density Semantic Segmentation with Probability Scaling for BI-RADS Assessment using DeepLabV3
Testagrose, Conrad , Gupta, Vikash , Erdal, Barbaros S. , White, Richard D. , Maxwell, Robert W. , Liu, Xudong , Kahanda, Indika , Elfayoumy, Sherif , Klostermeyer, William F. , Demirer, Mutlu , White, Richard D , Erdal, Barbaros S , Demirer, Mutlu , Gupta, Vikash

Proceedings of the 14th ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics | October 4, 2023 | Volume: No volume available | Issue: No issue available | Pages: 1-6

10.1145/3584371.3612983 Get It

Evaluating Drug Effectiveness for Antihypertensives in Heart Failure Prognosis: Leveraging Composite Clinical Endpoints and Biomarkers from Electronic Health Records
Chowdhury, Shaika , Chen, Yongbin , Ma, Xiao , Dai, Qiying , Yu, Yue , Zong, Nansu , Ma, Xiao , Chowdhury, Shaika

Proceedings of the 14th ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics | October 4, 2023 | Volume: No volume available | Issue: No issue available | Pages: 1-6

10.1145/3584371.3612977 | PMID 41527552 Get It

Comorbidities in mild autonomous cortisol secretion and the effect of treatment: systematic review and meta-analysis
Pelsma, Iris C. M. , Faßnacht, Martin , Tsagarakis, Stylianos , Tabarin, Antoine , Sahdev, Anju , Newell‐Price, John , Marina, Ljiljana V. , Arlt, Wiebke , Dekkers, Olaf M, Tabarin, Antoine , Newell-Price, John , Bancos, Irina , Arlt, Wiebke , Marina, Ljiljana V , Fassnacht, Martin , Pelsma, Iris , Terzolo, Massimo , Lorenz, Kerstin , Bancos, Irina , Dekkers, Olaf M.

European Journal of Endocrinology | October 4, 2023 | Volume: 189 | Issue: 4 | Pages: S88-S101

10.1093/ejendo/lvad134 | PMID 37801655 Get It

Abstract Objective To assess (1) comorbidities associated with and (2) treatment strategies for patients with adrenal incidentalomas and mild autonomous cortisol secretion (MACS; > 1.8 µg/dL (>50 nmol/L) cortisol level cut-off following the 1 mg dexamethasone suppression test). Design Systematic review and meta-analysis. Methods Seven databases were searched up to July 14, 2022. Eligible studies were (randomized) trials, cohort studies, and cross-sectional studies assessing comorbidities potentially attributable to cortisol excess or mortality in patients with adrenal incidentaloma with or without MACS or the effects of conservative or surgical management of MACS. Random-effects meta-analysis was performed to estimate pooled proportions (with 95% CIs). Results In 30 cross-sectional and 16 cohort studies (n = 17 156 patients in total), patients with MACS had a higher prevalence of diabetes (relative risk [RR] 1.44 [1.23-1.69]), hypertension (RR = 1.24 [1.16-1.32]), and dyslipidemia (RR = 1.23 [1.13-1.34]). All-cause mortality (adjusted for confounders) in patients with MACS, assessed in 4 studies (n = 5921), was increased (hazard ratio [HR] = 1.54 [1.27-1.81]). Nine observational studies (n = 856) and 2 randomized trials (n = 107) suggest an improvement in glucometabolic control (RR = 7.99 [2.95-21.90]), hypertension (RR = 8.75 [3.99-19.18]), and dyslipidemia (RR = 3.24 [1.19-8.82]) following adrenalectomy. Conclusions The present systematic review and meta-analysis highlight the relevance of MACS, since both cardiometabolic morbidities and mortality appeared to have increased in patients with MACS compared to patients with non-functioning incidentalomas. However, due to heterogeneous definitions, various outcomes, selective reporting, and missing data, the reported pooled estimates need to be interpreted with caution. The small number of patients in randomized trials prevents any strong conclusion on the causality between MACS and these comorbidities.
Left bundle branch area pacing too far away from the tricuspid annulus may cause pacing induced cardiomyopathy
Meyers, Michael C. , Liu, Xiaoke , Meyers, Michael, Meyers, Michael

Pacing and Clinical Electrophysiology | October 4, 2023 | Volume: 46 | Issue: 11 | Pages: 1333-1336

10.1111/pace.14837 | PMID 37793054 Get It

Abstract Background Physiologic pacing through left bundle branch area pacing (LBBAP) has recently been shown to be a very promising alternative for cardiac resynchronization therapy (CRT) and to avoid pacing induced cardiomyopathy. However, it is not clear whether the position of LABBP lead may affect the clinical outcomes. Case Report We here report a case of likely LBBAP induced worsening heart failure and cardiomyopathy reversed by re‐positioning of the pacing lead towards a more annular position. A 70‐year‐old male with a previous history of non‐ischemic dilated cardiomyopathy (ejection fraction 40%) who developed intermittent complete heart block and required permanent ventricular pacing. LBBAP was performed with the lead positioned to a position relatively far away from the tricuspid annulus (3.7 cm), due to difficulty in fixating the lead deep into the septum at a more annular position. One month post procedure, the patient's heart failure symptoms worsened, and his EF decreased to 31% despite good heart failure management. He underwent CRT upgrade with successful revision of the originally implanted LBBAP lead to a more annular position, using a deflectable delivery sheath. This resulted in further narrowing of the paced QRS duration from 135 to 106 ms. Two months post procedure, his heart failure symptoms improved by one functional class, and EF improved to 41% by echocardiogram. Conclusions LBBAP may be harmful when the lead is placed too far away from the annulus and may cause paced induced cardiomyopathy.
Response to Mukhdomi and colleagues
Schwenk, Eric S. , Porter, Steven B , Schwenk, Eric S , Porter, Steven B.

Regional Anesthesia & Pain Medicine | October 4, 2023 | Volume: 49 | Issue: 9 | Pages: 696.2-697

10.1136/rapm-2023-104865 | PMID 37793913 Get It

Increasing Incidence and Decreasing Mortality of Melanoma in Elderly Adults: An Epidemiologic Study in Olmsted County, Minnesota
Proffer, Sydney L. , Reinhart, Jacob P. , Campbell, Elliott H. , Gibson, Lawrence E. , Brewer, Jerry D., Demer, Addison M. , Crum, Olivia M. , Reinhart, Jacob

Dermatologic Surgery | October 4, 2023 | Volume: 50 | Issue: 2 | Pages: 125-130

10.1097/dss.0000000000003972 | PMID 37792642 Get It

BACKGROUND AND OBJECTIVE Primary cutaneous melanoma incidence is increasing in elderly individuals. This population-based cohort examines incidence and mortality rates among adults aged 61 years and older with cutaneous melanoma. MATERIALS AND METHODS Using the Rochester Epidemiology Project, patients aged 61 years of age or older with a first lifetime diagnosis of cutaneous melanoma between January 1, 1970 and December 31, 2020 were identified. RESULTS The age- and sex-adjusted incidence rate increased from 16.4 (95% CI, 8.2–24.6) per 100,000 person-years in 1970 to 1979 to 201.5 (95% CI, 185.1–217.8) per 100,000 person-years in 2011 to 2020 (12.3-fold increase). There was a 16.0x increase in males and an 8.5× increase in females. Melanoma incidence has stabilized in males (1.2-fold increase, p = .11) and continues to significantly increase in females (2.7-fold increase, p < .001). Older age at diagnosis was significantly associated with an increased risk of death (HR 1.23 per 5-year increase in age at diagnosis, 95% CI, 1.02–1.47). CONCLUSION Melanoma incidence continues to increase since 1970. The incidence has risen in elderly females, but has stabilized in males. Mortality has decreased throughout this period.
Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis
Murthy, Hemant S. , Zhang, Mei‐Jie , Chen, Karen , Ahmed, Sairah , Ganguly, Siddhartha , Kansagra, Ankit , Michelis, Fotios V. , Nishihori, Taiga , Patnaik, Mrinal M. , Aljurf, Mahmoud , Arai, Yasuyuki , Badar, Talha , Ballen, Karen K. , Bejanyan, Nelli , Brown, Valerie I. , Martino, Rodrigo , Cahn, Jean‐Yves , Castillo, Paul , Černý, Jan , Copelan, Edward A. , Daly, Andrew , Freytes, César O. , Hashmi, Shahrukh K. , Hildebrandt, Gerhard , Jamy, Omer , Joseph, Jacinth , Kanakry, Christopher G. , Khera, Nandita , Krem, Maxwell M. , Kuwatsuka, Yachiyo , Lekakis, Lazaros J. , Liu, Hongtao , Modi, Dipenkumar , Munshi, Pashna N. , Palmisiano, Neil , Rizzieri, David A. , Seo, Sachiko , Sharma, Akshay , Sohl, Melhm, Solomon, Scott R. , Ulrickson, Matthew L. , Üstün, Celalettin , Poel, Marjolein van der , Verdonck, Leo F. , Wagner, John L. , Wang, Trent , Wirk, Baldeep , Zeidan, Amer M. , Litzow, Mark R. , Weisdorf, Daniel J. , Saber, Wael , Kharfan‐Dabaja, Mohamed A. , Kansagra, Ankit , Michelis, Fotios V , Nishihori, Taiga , Patnaik, Mrinal , Arai, Yasuyuki , Badar, Talha , Bejanyan, Nelli , Bhatt, Vijaya Raj , Chhabra, Saurabh , Dholaria, Bhagirathbhai R , Diaz Perez, Miguel Angel , Freytes, Cesar O , Hashmi, Shahrukh K , Jamy, Omer , Krem, Maxwell M , Lazarus, Hillard M , Liu, Hongtao , Modi, Dipenkumar , Mussetti, Alberto , Patel, Sagar , Shah, Mithun V , Sharma, Akshay , Ustun, Celalettin , Wagner, John , Litzow, Mark R. , Hourigan, Christopher S , Weisdorf, Dan , Kharfan-Dabaja, Mohamed A , Murthy, Hemant S , Martino, Rodrigo , Ahmed, Sairah , Zeidan, Amer M , Deotare, Uday , Abid, Muhammad Bilal , Bacher, Ulrike , Badawy, Sherif M. , Battiwalla, Minoo , Beitinjaneh, Amer , Bhatt, Vijaya Raj , Chhabra, Saurabh , Dholaria, Bhagirathbhai , Díaz, Miguel Ángel , Grunwald, Michael R. , Lazarus, Hillard M. , Mussetti, Alberto , Patel, Sagar S. , Shah, Meera , Kebriaei, Partow , Hourigan, Christopher S.

Blood Advances | October 4, 2023 | Volume: 7 | Issue: 22 | Pages: 7007-7016

10.1182/bloodadvances.2023011308 | PMID 37792849 Get It

Abstract Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematological malignancy with a poor prognosis and considered incurable with conventional chemotherapy. Small observational studies reported allogeneic hematopoietic cell transplantation (allo-HCT) offers durable remissions in patients with BPDCN. We report an analysis of patients with BPDCN who received an allo-HCT, using data reported to the Center for International Blood and Marrow Transplant Research (CIBMTR). We identified 164 patients with BPDCN from 78 centers who underwent allo-HCT between 2007 and 2018. The 5-year overall survival (OS), disease-free survival (DFS), relapse, and nonrelapse mortality (NRM) rates were 51.2% (95% confidence interval [CI], 42.5-59.8), 44.4% (95% CI, 36.2-52.8), 32.2% (95% CI, 24.7-40.3), and 23.3% (95% CI, 16.9-30.4), respectively. Disease relapse was the most common cause of death. On multivariate analyses, age of ≥60 years was predictive for inferior OS (hazard ratio [HR], 2.16; 95% CI, 1.35-3.46; P = .001), and higher NRM (HR, 2.19; 95% CI, 1.13-4.22; P = .02). Remission status at time of allo-HCT (CR2/primary induction failure/relapse vs CR1) was predictive of inferior OS (HR, 1.87; 95% CI, 1.14-3.06; P = .01) and DFS (HR, 1.75; 95% CI, 1.11-2.76; P = .02). Use of myeloablative conditioning with total body irradiation (MAC-TBI) was predictive of improved DFS and reduced relapse risk. Allo-HCT is effective in providing durable remissions and long-term survival in BPDCN. Younger age and allo-HCT in CR1 predicted for improved survival, whereas MAC-TBI predicted for less relapse and improved DFS. Novel strategies incorporating allo-HCT are needed to further improve outcomes.
A De-embedded Pressure Drop Measurement Technique Coupled with Flow Network Analysis Software to Evaluate Pressure Drop Performance Curves for Direct Liquid Cooling Thermal Management Applications
Polzer, Stephen, Klitzke, Nicholas, Smutzer, Chad M., Wilkins, Wendy, Haider, Clifton R. , Gilbert, Barry K.

2023 39th Semiconductor Thermal Measurement, Modeling & Management Symposium (SEMI-THERM) | October 4, 2023 | Volume: No volume available | Issue: No issue available | Pages: 1-9

10.23919/semi-therm59981.2023.10267887 Get It

Genomic analysis of spermatocytic tumors demonstrates recurrent molecular alterations in cases with malignant clinical behavior
Gupta, Sounak , Sholl, Lynette M. , Osunkoya, Adeboye O. , Gordetsky, Jennifer , Cornejo, Kristine M. , Dvindenko, Eugénia, Hirsch, Michelle S. , Rowsey, Ross, Jiménez, Rafael E. , Cheville, John C. , Colecchia, Maurizio , Ricci, Costantino , Ulbright, Thomas M. , Snuderl, Matija , Rowsey, Ross A, Acosta, Andrés M , Gordetsky, Jennifer B , Yang, Yiying , Michalova, Kvetoslava , Maclean, Fiona M. , Snuderl, Matija , Anderson, William J. , Sadow, Peter M. , Berney, Daniel M. , Acosta, Andrés

The Journal of Pathology | October 4, 2023 | Volume: 262 | Issue: 1 | Pages: 50-60

10.1002/path.6210 | PMID 37792634 Get It

Abstract Spermatocytic tumor (ST) is a rare type of germ cell tumor that occurs exclusively in the postpubertal testis and typically affects elderly men. Most STs are benign, but rare cases exhibit aggressive clinical behavior, often in association with transition to sarcomatoid histology. Limited molecular analyses have been performed on STs; therefore, their genomic and epigenomic features remain incompletely described. Twenty‐seven samples from 25 individual patients were analyzed with a combination of DNA sequencing panels, genomic methylation profiling, SNP array, isochromosome (12p) [i(12p)] FISH, and immunohistochemistry. The series included five metastasizing tumors (three with sarcomatoid transformation, one anaplastic, and one conventional) and 20 non‐metastasizing tumors (14 anaplastic and six conventional). Anaplastic tumors comprised a monomorphic population of intermediate‐sized neoplastic cells, as previously described. Multiomic analyses demonstrated that there were two genomic subgroups of STs: one with diploid genomes and hotspot RAS / RAF variants and the other with global ploidy shift and absence of recurrent mutations. Relative gain of chromosome 9 was a consistent finding in both subgroups. A comparison of metastasizing and non‐metastasizing cases demonstrated that aggressive behavior was associated with the acquisition of pathogenic TP53 mutations and/or relative gains of 12p/i(12p). In cases with sarcomatoid transformation, TP53 mutations seem to underlie the transition to sarcomatoid histology. Genomic methylation analysis demonstrated that aggressive cases with gains of 12p cluster closer to pure seminomas than to STs without gains of 12p. In conclusion, STs include two genomic subgroups, characterized by global ploidy shifts without recurrent mutations and diploid genomes with RAS / RAF hotspot mutations, respectively. Biologic progression was associated with relative gains of 12p and TP53 mutations. The findings in STs with relative gains of 12p suggest that they may exhibit biologic characteristics akin to those seen in germ cell neoplasia in situ ‐related germ cell tumors rather than non‐germ cell neoplasia in situ ‐derived STs. © 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.